Angiogenesis and Stem Cell Research
The role of progenitor cells in cardiac repair
Noel M. Caplice, University College, Cork, Ireland
Functional improvement following direct injection of mesenchymal stem cells
Keith A. Horvath, National Heart, Lung and Blood Institute, Bethesda MD, USA
New approaches for cardiac reconstruction
Jonathan Leor, Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel
Vascular tissue engineering
Moshe Y. Flugelman, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Haifa, Israel
Therapeutic angiogenesis - lessions learned and homework to be done
Johannes Waltenberger, University of Maastricht, The Netherlands
MR tracking of step-progenitor cells
Xiaoming Yang, University of Washington School of Medicine, Seattle WA, USA
Circulating stem/progenitor cells as cardiovascular risk biomarkers
Gian Paolo Fadini, University of Padova, Italy
Basic Research, Molecular Biology
Macrophage foam cell formation mediated by receptor-independent,
fluid-phase pinocytosis of LDL
Howard S. Kruth, National Heart, Lung and Blood Institute, Bethesda MD, USA
Nuclear proteins in heart disease
Hartmut Schmidt, Universitatsklinikum Muenster, Muenster, Germany
Targeting stem cell signaling for cardiovascular repair
Carlo Ventura, University of Bologna, Bologna, Italy
Developmental aspect of cardiac sensitivity to ischemia - protective mechanisms in the immature heart
B. Ostadal, Academy of Sciences of the Czech Republic, Prague, Czech Republic
GRK2, a key regulator of cardiovascular function
Federico Mayor, Jr, Universidad Autonoma, Madrid, Spain
Vascular Biology
Endothelial function - from bench to clinical practice.
Amir Lerman, Mayo Clinic, Rochester MN, USA
Estrogen, aging and vascular function
Anne Knowlton, University of California Davis, Sacramento CA, USA
Atherogenesis and Atherosclerosis
Mechanisms of transition from stable atherosclerosis to acute coronary syndromes
Attilio Maseri, San Raffaele University Hospital, Milan, Italy
Aorta remodeling to distinct atherogenic stimuli: hypertension, hypercholesterolemia and turbulent flow/low wall shear stress
Marcos A. Rossi, Faculty of Medicione of Ribeirao Preto, Ribeirao Preto, SP, Brazil
Natural history of fetal coronary atherosclerosis from smoking mothers
Luigi Matturri, University of Milan, Milano, Italy
Epidemiology and Prevention
CV risk and prevention in 2010 - how low do you go?
Sandeep Gupta, Whipp's Cross and Bartholomew's Hospitals, London, UK
The impact of metabolic syndrome and its components on target organ damage: does a gender difference exist?.
Maria Grazia Modena, University of Modena and Peggio Emilia, Modena, Italy
Systemic atherosclerosis and cardiovascular disease risk
Nathan D. Wong, University of California Irvine, Irvine CA, USA
The up-to-date approach to screening in asymptomatic individuals: medical, ethical and financial issues
Shlomo Stern, The Hebrew University, Jerusalem, Israel
Myocardial Ischemia and Hibernation
Integrating diagnostic tests for hibernating myocardium into clinical practice
Shahbudin H. Rahimtoola, University of Southern California School of Medicine, Los Angeles CA, USA
Pre and postconditioning: from bench to bedside
Dimitrios T. Kremastinos, University Hospital Atticon, Athens, Greece
Cardioprotection by anti-diabetic agents: lessons from the rat and mouse models
Yochai Birnbaum, University of Texas Medical Branch, Galveston TX, USA
Acute Coronary Syndromes, Acute Myocardial Infarction
The new definition of myocardial infarction: what needs to be clarified?
Joseph S. Alpert, University of Arizona Health Sciences Center, Tucson AZ, USA
Hub and spoke organization for the management of patients with acute myocardial infarction
Giuseppe Di Pasquale, Ospedale Maggiore, Bologna, Italy
The first case of local intracoronary thrombolysis in STEMI patients
Mikhail Y. Ruda, National Cardiology Research Center, Moscow, Russia
Revascularization for diabetic patients with ACS
John Lekakis, Alexandra University Hospital, Athens, Greece
Preventing reperfusion injury in STEMI: Insights from the FIRE-trial
Dan Atar, Aker University Hospital, Trondheimsvn, Oslo, Norway
STEMI and healing in the elderly: new insights
Bodh I. Jugdutt, University of Alberta Hospitals, Edmonton, Alberta, Canada
Myocardial remodeling - from bench to bedside
Dennis V. Cokkinos, Onassis Cardiac Surgery Center, Athens, Greece
Why the cardiologists don’t follow the guidelines
Gerasimos Filippatos, University Hospital of Athens, Athens, Greece
New Diagnostic and Imaging Techniques
Screening for silent myocardial ischemia in asymptomatic patients with type 2 diabetes mellitus and subsequent 5-year cardiac outcome
Frans J.Th. Wackers, Yale University, School of Medicine, New Haven CT, USA
Coronary CT angiography: from 64 to 320 detector MDCT
Vassilios Raptopoulos, Beth-Israel-Deaconess Medical Center, Boston MA, USA
Cardiac CTA: 2009 update on outcome studies
Andre Duerinckx, Howard University College of Medicine, Washington, DC, USA
The nature of coronary plaque in asymptomatic diabetics: Can we predict outcomes form coronary CT angiography?
David A. Halon, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Haifa, Israel
Recent developments in speckle tracking: quantitative analysis of 3 layers of the LV myocardium
Zvi Vered, Assaf Harofeh Medical Center and Tel Aviv University, Zerifin, Israel
Hypertension
Ambulatory blood pressure as a risk predictor in coronary heart disease
Andrzej Rynkiewicz, Medical University of Gdansk, Gdansk, Poland
Brachial blood pressure: What it tells us and what it doesn't. Central blood pressure and vascular damage.
Reuven Zimlichman, Wolfson Medical Center and Tel Aviv University, Holon, Israel
cardiac function and Heart Failure
Population-based survival of patients with a new diagnosis of heart failure
George C. Sutton, Imperial College School of Medicine, London, UK
Differential matrix metalloproteinase proteomic profiling in patients at risk for heart failure: diagnostic and prognostic implications for personalized medicine
Francis G. Spinale, Medical University of South Carolina, Charleston SC, USA
Problems of guidïng treatment of chronic heart failure by plasma natriuretic peptide levels
Jaromir Hradec, Charles University, Praha, Czech Republic
Therapeutic aspects, Pharmacotherapy
Updates in anticoagulation and antiplatelet therapy in acute coronary syndromes
Timothy A. Sanborn, Evanston Northwestern Healthcare, Evanston IL, USA
Stable angina: Treatment update 2009. What is new and what works?
Udho Thadani, University of Oklahoma, Oklahoma City OK, USA
The role of heart rate modulation in managing patients with coronary artery disease
Jeffrey S. Borer, The New York Hospital, Cornell Medical Center, New York NY, USA
Types of antiischemic therapy in the post CABG symptomatic patient
Igor Riecansky, Slovak Institute of Cardiovascular Diseases, Bratislava, Slovakia
Electrocardiography and Electrophysiology, Cardiac Arrhythmias
Arrhythmias in percutanous coronary interventions
Bulent Gorenek, Osmangazi University, Eskisehir, Turkey
Interventional Cardiology and Stenting
Primary PCI for STEMI: long-term outcomes
Petr Widimsky, Cardiocenter Vincheadt, Charles University, Praha, Czech Republic
Treatment of the left main lesion: Is stenting the new standard?
Barry Uretsky, Sparks Cardiology & Cardiovascular Services, Fort Smith AR, USA
Evidence based practice or practice with lack of evidence? Therapeutic strategy after coronary angiography
Yoseph Rozenman, Wolfson Medical Center and Tel Aviv University, Holon, Israel
A comprehensive analysis of DES vs BMS outcomes in the "real world" of PCI practice
Ran Kornowski, Rabin Medical Center and Tel Aviv University, Tel Aviv, Israel
PCI with DES in saphenous vein graft lesions: long-term results
Vassilis Voudris, Onassis Cardiac Surgery Center, Athens, Greece
Percutaneous coronary intervention in the elderly
Morris Mosseri, Meir Medical Center and Tel Aviv University, Kfar Saba, Israel
Interventional management strategies in patients with impaired left ventricular function
George W. Vetrovec, Virginia CUHS, Richmond VA, USA
Nanoparticles for immunomodulation and restenosis therapy in clinical studies
Gershon Golomb, The Hebrew University, Jerusalem, Israel
History and defining features of coronary stents
Kobi Richter, Har Hotzvim, Jerusalem, Israel
Carotid and Peripheral Intervention
Endovascular treatment of carotid arteriosclerotic stenotic disease: how to avoid embolic complications
Jiri J. Vitek, Lenox Hill Heart and Vascular Institute, New York NY, USA
Current status of interventional treatment of peripheral arterial disease
Nicholas N. Kipshidze, Lenox Hill Heart and Vascular Institute, New York NY, USA
Cardiac Surgery
Long term follow-up after surgery for acute evolving myocardial infarction
Shuli Silberman, Shaarei Zedek Medical Center, Jerusalem, Israel
Endoscopic vein harvest utilizing a single incision technique: review of >1000 consecutive cases
Kathy E. Magliato, St Johns Medical Center, Los Angeles CA, USA
Impact of coronary disease on valve surgery outcomes
Bernard S. Goldman, Sunnybrook Health Science Center, Toronto, Ontario, Canada
Surgical options for end-stage heart failure in coronary artery disease
Roland Hetzer, German Heart Institute, Berlin, Germany
Redo coronary artery bypass surgery
John Wallwork, Papworth Hospital, Cambridge University, UK
First experience with percutaneous valve replacement using the new retrievable and removable direct flow valve in combination with PCI
Hermann Reichenspurner, Universitatsklinikum Eppendorf, Hamburg, Germany